What is Albemarle Corporation's earnings per share (EPS)?

Albemarle Corporation (ALB) reported diluted earnings per share of -$5.76 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Albemarle Corporation (ALB) Financials

ALB NYSE

Trailing 12 months to June 30, 2026

Revenue $5.9B +18.3% YoY

Net Income $224.2M n/m YoY

EPS (Diluted) $0.26 n/m YoY

Free Cash Flow $1.3B n/m YoY

Market Cap $11.0B as of Oct 26, 2026

Price / Sales 1.9x on $5.9B revenue, trailing 12 months to June 30, 2026

Price / Earnings 49.2x on $224.2M net income, trailing 12 months to June 30, 2026

Price / Book 1.1x on $10.3B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALB SEC filings page.

Albemarle Corporation (ALB) reported $5.9B in revenue over the twelve months to Jun 30, 2026, up 18.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ALB FY2025 2026-10-26

Albemarle’s cash recovery came from lower reinvestment and working-capital needs, while operating earnings remained negative despite gross-margin improvement.

The 2025 cash rebound came more from a smaller reinvestment bill than from a stronger earnings engine: operating cash flow rose 86.4% while capital expenditures fell 64.9%, producing free cash flow of $692M despite a net loss of $511M. That divergence means reported cash generation improved before the income statement fully recovered.

Revenue fell 4.4%, yet gross margin recovered 11.8 percentage points to 13.0% as cost of revenue fell faster than sales. However, the company still posted an operating loss of $367M and a -7.1% operating margin, showing that restored product-level economics were not enough to absorb the remaining operating burden.

Working capital contracted: inventory fell 21.5% and receivables fell 20.0%, while the current ratio reached 2.2x; that combination supports cash generation even while earnings were negative. Long-term debt was essentially unchanged, and liabilities were 41.8% of assets, so the cash improvement did not depend on increased long-term borrowing.

Financial Health Signals

Financial Health Score 23/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Albemarle Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Albemarle Corporation has an operating margin of -7.1%, meaning the company loses $7 on every $100 of revenue. This results in a profitability score of 12/100. This is up from -33.0% the prior year.

Growth

Albemarle Corporation's revenue declined 4.4% year-over-year, from $5.4B to $5.1B. This contraction results in a growth score of 3/100.

Leverage

Albemarle Corporation has elevated debt relative to equity (D/E of 0.33), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 11/100, reflecting increased financial risk.

Liquidity

With a current ratio of 2.23, Albemarle Corporation holds $2.23 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 65/100.

Cash Flow

Albemarle Corporation's free cash flow margin of 13.5% results in a low score of 25/100. Capital expenditures of $589.8M absorb a large share of operating cash flow.

Returns

Albemarle Corporation posts a -5.4% return on equity (ROE), meaning it loses $5 for every $100 of shareholders' equity. This results in a returns score of 19/100. This is up from -11.8% the prior year.

Altman Z-Score Distress

1.76

Albemarle Corporation scores 1.76, below the 1.81 distress threshold. The score is pulled down most by an operating loss of $367.1M against total assets of $16.4B. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

Albemarle Corporation passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality Mixed

N/A

Albemarle Corporation reported a net loss of $510.6M while generating $1.3B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Albemarle Corporation reported an operating loss of $367.1M against $207.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.7B

YoY+31.1%

QoQ+22.0%

5Y CAGR+17.6%

10Y CAGR+10.0%

Albemarle Corporation generated $1.7B in revenue in Q2 2026. This represents an increase of 31.1% from the same quarter a year earlier. Against the prior quarter it is up 22.0%.

EBITDA

$608.7M

YoY+181.5%

QoQ+55.6%

5Y CAGR+0.2%

Albemarle Corporation's EBITDA was $608.7M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 181.5% from the same quarter a year earlier. Against the prior quarter it is up 55.6%.

Net Income

$480.0M

YoY+1996.2%

QoQ+50.4%

5Y CAGR+2.5%

10Y CAGRn/m

Albemarle Corporation reported $480.0M in net income in Q2 2026. This represents an increase of 1996.2% from the same quarter a year earlier. Against the prior quarter it is up 50.4%.

EPS (Diluted)

$3.52

YoYn/m

QoQ+50.4%

Albemarle Corporation earned $3.52 per diluted share (EPS) in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 50.4%.

Cash & Balance Sheet

Free Cash Flow

$638.3M

YoYn/m

QoQ+157.8%

5Y CAGR+126.6%

10Y CAGR+32.3%

Albemarle Corporation generated $638.3M in free cash flow in Q2 2026, representing cash available after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 157.8%.

Cash & Debt

$1.6B

YoY-9.7%

QoQ+49.7%

5Y CAGR+14.7%

10Y CAGR+23.8%

Albemarle Corporation held $1.6B in cash against $1.8B in long-term debt as of Q2 2026.

Dividends Per Share

$0.41

YoY0.0%

QoQ0.0%

Albemarle Corporation paid $0.41 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

118M

YoY+0.3%

QoQ+0.1%

Albemarle Corporation had 118M shares outstanding in Q2 2026. This represents an increase of 0.3% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Margins & Returns

Gross Margin

33.9%

YoY+19.1pp

QoQ-1.2pp

5Y change+1.8pp

10Y change-3.2pp

Albemarle Corporation's gross margin was 33.9% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 19.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.2 percentage points.

Operating Margin

26.0%

YoY+22.4pp

QoQ+9.6pp

5Y change-44.1pp

Albemarle Corporation's operating margin was 26.0% in Q2 2026, reflecting core business profitability. This is up 22.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.6 percentage points.

Net Margin

27.5%

YoY+25.8pp

QoQ+5.2pp

5Y change-27.3pp

10Y change+74.6pp

Albemarle Corporation's net profit margin was 27.5% in Q2 2026, showing the share of revenue converted to profit. This is up 25.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.2 percentage points.

Return on Equity

4.7%

YoY+4.5pp

QoQ+1.4pp

5Y change-2.2pp

10Y change+14.6pp

Albemarle Corporation's quarterly ROE was 4.7% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 4.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.

Capital Allocation

R&D Spending

$3.7M

YoY-70.5%

QoQ-60.0%

5Y CAGR-23.5%

Albemarle Corporation invested $3.7M in research and development in Q2 2026. This represents a decrease of 70.5% from the same quarter a year earlier. Against the prior quarter it is down 60.0%.

Capital Expenditures

$71.7M

YoY-40.0%

QoQ-27.3%

5Y CAGR-19.9%

10Y CAGR+5.7%

Albemarle Corporation invested $71.7M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 40.0% from the same quarter a year earlier. Against the prior quarter it is down 27.3%.

Share Buybacks

Not reported for Q2 2026.

ALB Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALB quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$5.9B	$5.1B-4.4%	$5.4B-44.1%	$9.6B+31.4%	$7.3B+120.0%	$3.3B+6.4%	$3.1B-12.8%	$3.6B+6.4%	$3.4B+9.9%	$3.1B+14.7%	$2.7B-5.3%	$2.8B+15.6%	$2.4B+2.1%	$2.4B-5.0%	$2.5B-5.0%	$2.7B
Cost of Revenue	$4.5B	$4.5B-15.8%	$5.3B-37.0%	$8.4B+98.6%	$4.2B+82.2%	$2.3B+9.2%	$2.1B-8.5%	$2.3B+8.1%	$2.2B+9.8%	$2.0B+15.2%	$1.7B-13.2%	$2.0B+17.4%	$1.7B+8.5%	$1.5B-4.7%	$1.6B-4.7%	$1.7B
Gross Profit	$1.4B	$668.7M+969.3%	$62.5M-94.7%	$1.2B-61.4%	$3.1B+208.1%	$998.0M+0.3%	$994.9M-20.9%	$1.3B+3.3%	$1.2B+10.0%	$1.1B+14.0%	$970.3M+12.8%	$860.2M+11.6%	$770.8M-9.4%	$850.5M-5.4%	$898.8M-5.6%	$951.7M
R&D Expenses	$37.7M	$51.4M-40.7%	$86.7M+1.2%	$85.7M+19.1%	$72.0M+33.2%	$54.0M-8.8%	$59.2M+1.6%	$58.3M-16.8%	$70.1M-16.9%	$84.3M+4.8%	$80.5M-9.8%	$89.2M+1.0%	$88.3M+7.4%	$82.2M+4.2%	$78.9M+2.4%	$77.1M
SG&A Expenses	$557.8M	$550.0M-11.0%	$618.0M-32.1%	$910.0M+73.6%	$524.1M+18.7%	$441.5M+2.7%	$429.8M-19.4%	$533.4M+19.6%	$446.1M-0.9%	$450.3M+27.3%	$353.8M+17.7%	$300.4M-15.4%	$355.1M+124.5%	$158.2M-48.7%	$308.5M-13.1%	$354.9M
Operating Income	$252.1M	-$367.1Mn/m	-$1.8B-805.3%	$251.9M-89.8%	$2.5B+209.4%	$798.4M+57.9%	$505.8M-24.1%	$666.1M-26.9%	$911.5M+59.5%	$571.7M-4.9%	$601.0M+74.1%	$345.1M+27.2%	$271.3M-53.0%	$576.7M+44.2%	$399.8M-23.1%	$519.7M
EBITDA	N/A	$291.6Mn/m	-$1.2B-274.2%	$681.8M-75.4%	$2.8B+163.3%	$1.1B+42.6%	$737.8M-16.1%	$879.6M-20.9%	$1.1B+44.7%	$768.6M-7.1%	$827.1M+36.7%	$605.2M+61.4%	$374.9M-45.2%	$684.0M+37.1%	$498.8M-19.1%	$616.5M
Interest Expense	$172.8M	$207.7M+25.4%	$165.6M+42.7%	$116.1M-5.6%	$123.0M+100.0%	$61.5M-15.9%	$73.1M+26.7%	$57.7M+10.1%	$52.4M-54.6%	$115.3M+77.0%	$65.2M-20.2%	$81.7M+97.4%	$41.4M+31.0%	$31.6M-3.8%	$32.8M-12.7%	$37.6M
Income Tax	$242.3M	$156.9M+80.1%	$87.1M-79.8%	$430.3M+10.2%	$390.6M+1226.5%	$29.4M-45.9%	$54.4M-38.3%	$88.2M-39.1%	$144.8M-66.5%	$431.8M+348.6%	$96.3M+764.6%	$11.1M-39.8%	$18.5M-86.3%	$134.4M+67.2%	$80.4M-23.0%	$104.5M
Net Income	$224.2M	-$510.6Mn/m	-$1.2B-175.0%	$1.6B-41.5%	$2.7B+2075.0%	$123.7M-67.1%	$375.8M-29.5%	$533.2M-23.1%	$693.6M+1164.5%	$54.9M-91.5%	$643.7M+92.2%	$334.9M+151.2%	$133.3M-67.7%	$413.2M+32.6%	$311.5M-20.5%	$392.1M
EPS (Basic)	N/A	-$5.76n/m	-$11.20-183.5%	$13.41-41.6%	$22.97+2046.7%	$1.07-69.7%	$3.53-29.8%	$5.03-21.4%	$6.40+1206.1%	$0.49-91.4%	$5.73+90.4%	$3.01+78.1%	$1.69-65.7%	$4.93+41.3%	$3.49-19.4%	$4.33
EPS (Diluted)	$0.26	-$5.76n/m	-$11.20-183.8%	$13.36-41.5%	$22.84+2054.7%	$1.06-69.9%	$3.52-29.9%	$5.02-20.8%	$6.34+1193.9%	$0.49-91.4%	$5.68+89.3%	$3.00+77.5%	$1.69-65.5%	$4.90+41.2%	$3.47-18.9%	$4.28
Diluted Shares (Avg)	N/A	118M+0.1%	118M-0.2%	118M0.0%	118M+1.1%	117M+9.1%	107M+0.5%	106M-2.9%	109M-2.6%	112M-0.8%	113M+1.5%	112M+41.0%	79M-6.2%	84M-6.2%	90M-1.8%	92M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$1.7B+31.1%	$1.4B+32.7%	$1.4B+15.9%	$1.3B-3.5%	$1.3B-7.0%	$1.1B-20.9%	$1.2B-47.7%	$1.4B-41.4%
Cost of Revenue	$1.2B+1.8%	$927.8M+0.8%	$1.2B+12.5%	$1.2B-18.4%	$1.1B-21.4%	$920.6M-30.4%	$1.1B-64.3%	$1.5B-35.3%
Gross Profit	$590.3M+199.8%	$501.0M+220.5%	$197.9M+43.2%	$117.6Mn/m	$196.9Mn/m	$156.3M+301.4%	$138.2Mn/m	-$104.0M-289.4%
R&D Expenses	$3.7M-70.5%	$9.2M-35.0%	$12.2M-39.2%	$12.7M-43.4%	$12.4M-40.1%	$14.1M-40.1%	$20.0M-12.0%	$22.4M+6.2%
SG&A Expenses	$126.4M-4.6%	$137.4M+11.3%	$155.5M+14.3%	$138.6M-10.2%	$132.5M-20.4%	$123.5M-23.5%	$136.0M-27.1%	$154.3M-10.4%
Operating Income	$452.9M+853.0%	$233.5M+1081.7%	-$217.4M-5038.3%	-$217.0Mn/m	$47.5Mn/m	$19.8Mn/m	$4.4Mn/m	-$1.1Bn/m
EBITDA	$608.7M+181.5%	$391.3M+115.6%	-$53.7M-132.0%	-$52.5Mn/m	$216.3Mn/m	$181.5Mn/m	$167.5Mn/m	-$945.3Mn/m
Interest Expense	$30.9M-38.1%	$33.1M-32.4%	$57.8M+29.2%	$51.0M+6.7%	$49.9M+41.9%	$49.0M+29.0%	$44.7M+30.0%	$47.8M+62.8%
Income Tax	$94.0M+175.7%	$21.5Mn/m	$157.3M+1382.4%	-$30.6M-127.6%	$34.1Mn/m	-$4.0Mn/m	$10.6M-91.1%	$110.9Mn/m
Net Income	$480.0M+1996.2%	$319.1M+671.7%	-$414.2M-650.1%	-$160.7Mn/m	$22.9Mn/m	$41.3M+1589.1%	$75.3Mn/m	-$1.1B-453.3%
EPS (Basic)	$3.72n/m	$2.35n/m	-$3.88	-$1.72n/m	-$0.16n/m	$0.00n/m	$0.29	-$9.45-466.3%
EPS (Diluted)	$3.52n/m	$2.34n/m	-$3.88	-$1.72n/m	-$0.16n/m	$0.00n/m	$0.29	-$9.45-467.7%
Diluted Shares (Avg)	136M+15.8%	119M+0.9%	N/A	118M+0.1%	118M+0.1%	118M+0.1%	N/A	118M-0.2%

ALB Balance Sheet

ALB quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$16.4B-1.4%	$16.6B-9.1%	$18.3B+18.2%	$15.5B+40.8%	$11.0B+5.0%	$10.5B+6.0%	$9.9B+30.1%	$7.6B-2.2%	$7.8B-5.0%	$8.2B-15.0%	$9.6B+84.5%	$5.2B+45.1%	$3.6B+4.3%	$3.4B+7.3%	$3.2B
Current Assets	$4.0B+4.3%	$3.8B-26.3%	$5.2B+0.6%	$5.2B+160.2%	$2.0B-9.6%	$2.2B-0.9%	$2.2B+11.3%	$2.0B-19.3%	$2.5B-25.1%	$3.3B+80.6%	$1.8B-45.3%	$3.3B+125.8%	$1.5B+5.4%	$1.4B+3.8%	$1.4B
Cash & Equivalents	$1.6B+35.7%	$1.2B+34.0%	$889.9M-40.6%	$1.5B+241.3%	$439.3M-41.2%	$746.7M+21.8%	$613.1M+10.4%	$555.3M-51.2%	$1.1B-49.9%	$2.3B+962.0%	$213.7M-91.4%	$2.5B+421.7%	$477.2M-0.1%	$477.7M+1.8%	$469.4M
Short-Term Investments	N/A	N/A	N/A	N/A	$0	N/A	N/A	N/A	N/A	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Inventory	$1.2B-21.5%	$1.5B-30.5%	$2.2B+4.1%	$2.1B+160.0%	$798.6M+6.4%	$750.2M-2.4%	$769.0M+9.8%	$700.5M+18.2%	$592.8M+31.7%	$450.3M+2.4%	$439.5M+22.6%	$358.4M-17.8%	$436.0M+1.8%	$428.1M-0.8%	$431.5M
Accounts Receivable	$593.5M-20.0%	$742.2M-38.8%	$1.2B+1.9%	$1.2B+113.8%	$556.9M+4.9%	$530.8M-13.4%	$612.7M+1.1%	$605.7M+13.4%	$534.3M+9.9%	$486.0M+22.1%	$397.9M+3.3%	$385.2M-13.8%	$446.9M+17.9%	$379.0M+6.6%	$355.4M
Long-Term Investments	$64.3M+6.1%	$60.6M-70.7%	$207.0M+423.7%	$39.5M+6.3%	$37.2M+0.2%	$37.1M+10.3%	$33.6M+0.4%	$33.5M+9.3%	$30.7M+11.2%	$27.6M+13.7%	$24.3M+1.2%	$24.0M+0.7%	$23.8M+17.3%	$20.3M+20.8%	$16.8M
Goodwill	$1.5B-5.2%	$1.6B-2.9%	$1.6B+0.7%	$1.6B+1.3%	$1.6B-4.1%	$1.7B+5.5%	$1.6B+0.7%	$1.6B-2.7%	$1.6B+4.6%	$1.5B+5.4%	$1.5B+500.4%	$243.3M-14.4%	$284.2M+2.6%	$277.0M+1.4%	$273.1M
Total Liabilities	$6.8B+2.9%	$6.6B-25.0%	$8.9B+18.5%	$7.5B+39.7%	$5.3B-13.5%	$6.2B+4.3%	$5.9B+48.4%	$4.0B-2.0%	$4.1B-6.6%	$4.4B-31.2%	$6.3B+65.1%	$3.8B+96.3%	$2.0B+22.1%	$1.6B-0.5%	$1.6B
Current Liabilities	$1.8B-8.6%	$2.0B-44.8%	$3.6B+29.9%	$2.7B+46.2%	$1.9B+4.0%	$1.8B+27.9%	$1.4B+19.1%	$1.2B-1.5%	$1.2B+5.3%	$1.1B-29.5%	$1.6B+41.8%	$1.1B+161.2%	$436.4M+13.3%	$385.0M-4.0%	$401.2M
Non-Current Liabilities	$5.0B+7.7%	$4.7B-11.6%	$5.3B+11.9%	$4.7B+36.2%	$3.5B-20.7%	$4.4B-3.1%	$4.5B+60.7%	$2.8B-2.2%	$2.9B-10.9%	$3.2B-31.8%	$4.7B+74.9%	$2.7B+77.7%	$1.5B+24.8%	$1.2B+0.6%	$1.2B
Long-Term Debt	$3.1B0.0%	$3.1B-11.9%	$3.5B+10.1%	$3.2B+60.4%	$2.0B-27.6%	$2.8B-3.3%	$2.9B+104.8%	$1.4B-1.2%	$1.4B-33.3%	$2.1B-32.5%	$3.1B+41.3%	$2.2B+110.9%	$1.1B+53.6%	$686.6M-8.4%	$749.3M
Total Equity	$9.5B-4.3%	$10.0B+5.8%	$9.4B+17.9%	$8.0B+41.9%	$5.6B+31.8%	$4.3B+8.5%	$3.9B+9.7%	$3.6B-2.4%	$3.7B-3.2%	$3.8B+16.6%	$3.3B+139.4%	$1.4B-16.5%	$1.6B-11.2%	$1.8B+15.2%	$1.6B
Retained Earnings	$4.6B-15.8%	$5.5B-21.5%	$7.0B+24.7%	$5.6B+80.9%	$3.1B-1.9%	$3.2B+7.2%	$2.9B+14.7%	$2.6B+26.1%	$2.0B-4.1%	$2.1B+31.4%	$1.6B+14.5%	$1.4B-6.0%	$1.5B-14.0%	$1.7B+15.2%	$1.5B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$15.9B-8.0%	$15.1B-10.9%	$16.4B-1.4%	$17.1B-1.8%	$17.3B-6.0%	$17.0B-10.7%	$16.6B-9.1%	$17.5B-7.6%
Current Assets	$3.9B-12.5%	$3.3B-20.6%	$4.0B+4.3%	$4.6B-2.5%	$4.5B-13.8%	$4.1B-29.5%	$3.8B-26.3%	$4.7B-34.5%
Cash & Equivalents	$1.6B-9.7%	$1.1B-28.2%	$1.6B+35.7%	$1.9B+16.1%	$1.8B-1.3%	$1.5B-26.1%	$1.2B+34.0%	$1.7B+3.9%
Inventory	$1.4B-15.6%	$1.3B-18.7%	$1.2B-21.5%	$1.5B-7.5%	$1.6B-8.8%	$1.7B-13.0%	$1.5B-30.5%	$1.7B-51.3%
Accounts Receivable	$603.8M-21.2%	$522.7M-22.1%	$593.5M-20.0%	$733.5M-2.2%	$766.4M-2.4%	$670.8M-23.3%	$742.2M-38.8%	$749.8M-36.4%
Long-Term Investments	$1.1B+24.6%	$1.0B-9.1%	$64.3M+6.1%	$914.0M-22.5%	$890.4M-23.3%	$1.1B-10.7%	$60.6M-70.7%	$1.2B-5.9%
Goodwill	$1.5B-11.3%	$1.5B-7.3%	$1.5B-5.2%	$1.5B-9.0%	$1.7B+4.4%	$1.6B-0.5%	$1.6B-2.9%	$1.6B+2.0%
Total Liabilities	$5.6B-20.2%	$5.3B-24.1%	$6.8B+2.9%	$7.2B-0.9%	$7.1B-1.6%	$7.0B-7.0%	$6.6B-25.0%	$7.2B-19.7%
Current Liabilities	$1.9B-3.0%	$1.6B-18.9%	$1.8B-8.6%	$2.0B+4.9%	$1.9B-0.4%	$1.9B-5.2%	$2.0B-44.8%	$1.9B-51.5%
Non-Current Liabilities	$3.7B-26.7%	$3.7B-26.1%	$5.0B+7.7%	$5.1B-2.9%	$5.1B-2.0%	$5.0B-7.7%	$4.7B-11.6%	$5.3B+5.2%
Long-Term Debt	$1.8B-43.3%	$1.8B-42.2%	$3.1B0.0%	$3.2B-10.8%	$3.2B-9.7%	$3.1B-11.1%	$3.1B-11.9%	$3.6B+2.0%
Total Equity	$10.3B+0.3%	$9.9B-1.8%	$9.5B-4.3%	$10.0B-2.4%	$10.2B-8.8%	$10.0B-13.0%	$10.0B+5.8%	$10.2B+3.5%
Retained Earnings	$5.2B-2.5%	$4.8B-10.9%	$4.6B-15.8%	$5.1B-6.9%	$5.4B-19.3%	$5.4B-21.6%	$5.5B-21.5%	$5.5B-28.2%

Not reported in any period shown, so not listed: Short-Term Investments.

ALB Cash Flow Statement

ALB quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$1.8B	$1.3B+86.4%	$687.9M-48.1%	$1.3B-30.6%	$1.9B+455.5%	$344.3M-56.9%	$798.9M+11.1%	$719.4M+31.7%	$546.2M+79.7%	$304.0M-58.7%	$735.5M+103.9%	$360.8M-26.8%	$492.6M+13.8%	$432.9M-11.4%	$488.8M+0.3%	$487.4M
Depreciation & Amortization	N/A	$658.7M+11.9%	$588.6M+36.9%	$429.9M+42.9%	$300.8M+18.4%	$254.0M+9.5%	$232.0M+8.7%	$213.5M+6.4%	$200.7M+1.9%	$196.9M-12.9%	$226.2M-13.0%	$260.1M+151.1%	$103.6M-3.5%	$107.4M+8.4%	$99.0M+2.3%	$96.8M
Stock-Based Compensation	N/A	$40.3M+25.3%	$32.1M-12.1%	$36.5M+19.9%	$30.5M+51.5%	$20.1M-11.9%	$22.8M+16.0%	$19.7M+29.2%	$15.2M-21.5%	$19.4M+13.9%	$17.0M+12.1%	$15.2M+6.5%	$14.3M+40.4%	$10.2M-33.2%	$15.2M-43.8%	$27.1M
Capital Expenditures	$458.0M	$589.8M-64.9%	$1.7B-22.0%	$2.2B+70.8%	$1.3B+32.3%	$953.7M+12.1%	$850.5M-0.2%	$851.8M+21.7%	$700.0M+120.3%	$317.7M+61.6%	$196.7M-13.6%	$227.6M+105.9%	$110.6M-28.8%	$155.3M-44.7%	$280.9M+47.4%	$190.6M
Free Cash Flow	$1.3B	$692.5Mn/m	-$992.7Mn/m	-$828.0M-227.2%	$650.8Mn/m	-$609.4Mn/m	-$51.6Mn/m	-$132.4Mn/m	-$153.8Mn/m	-$13.7M-102.5%	$538.9M+304.7%	$133.2M-65.1%	$382.0M+37.7%	$277.5M+33.5%	$207.9M-30.0%	$296.8M
Investing Cash Flow	$130.9M	-$146.0Mn/m	-$1.6Bn/m	-$2.6Bn/m	-$1.5Bn/m	-$666.6Mn/m	-$863.6Mn/m	-$1.7Bn/m	-$303.7Mn/m	-$357.8M-112.3%	$2.9Bn/m	-$2.2Bn/m	-$46.1Mn/m	-$157.7Mn/m	-$301.2Mn/m	-$212.9M
Financing Cash Flow	-$2.1B	-$834.2M-167.2%	$1.2B+99.0%	$623.9M+2.0%	$611.9M+1118.6%	$50.2M-71.7%	$177.3M-83.0%	$1.0Bn/m	-$786.5Mn/m	-$1.1Bn/m	-$1.6Bn/m	-$478.4M-129.7%	$1.6Bn/m	-$288.0Mn/m	-$177.3Mn/m	-$329.1M
Dividends Paid	$190.7M	$190.5M+1.1%	$188.5M+0.7%	$187.2M+1.5%	$184.4M+3.7%	$177.9M+9.9%	$161.8M+6.3%	$152.2M+5.3%	$144.6M+2.9%	$140.6M+3.8%	$135.4M+13.5%	$119.3Mn/m	$0n/m	$0n/m	$0-100.0%	$57.8M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	$0n/m	$0-100.0%	$500.0M+100.0%	$250.0Mn/m	$0n/m	$0-100.0%	$150.0M-74.2%	$582.3M+815.9%	$63.6M-64.3%	$178.1M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$710.0Mn/m	$346.2M-36.7%	$388.5Mn/m	$355.6M+56.6%	-$9.0M-102.5%	$547.2M+461.3%	-$4.4Mn/m	$227.1M-63.9%
Depreciation & Amortization	$155.8M-7.7%	$157.8M-2.4%	$163.7M+0.4%	$164.5M+0.6%	$168.7M+22.0%	$161.8M+30.7%	$163.1M+13.2%	$163.5M+55.1%
Stock-Based Compensation	N/A	$7.9M+13.2%	N/A	N/A	N/A	$7.0M-25.2%	N/A	N/A
Capital Expenditures	$71.7M-40.0%	$98.7M-46.0%	$155.4M-54.7%	$132.2M-56.4%	$119.6M-73.5%	$182.6M-68.7%	$342.8M-50.3%	$303.1M-44.5%
Free Cash Flow	$638.3Mn/m	$247.6M-32.1%	$233.1Mn/m	$223.4Mn/m	-$128.7Mn/m	$364.6Mn/m	-$347.2Mn/m	-$76.0M-191.6%
Investing Cash Flow	-$80.4M-125.7%	$541.0Mn/m	-$176.6Mn/m	-$153.0Mn/m	$312.7Mn/m	-$129.1Mn/m	-$328.5Mn/m	-$317.1Mn/m
Financing Cash Flow	-$80.1Mn/m	-$1.4Bn/m	-$533.0Mn/m	-$90.5Mn/m	-$90.6Mn/m	-$120.0M-107.7%	-$92.9M-123.4%	-$110.0M-210.3%
Dividends Paid	$47.7M+0.1%	$47.7M+0.1%	$47.6M+0.1%	$47.7M+1.4%	$47.6M+1.3%	$47.6M+1.5%	$47.6M+1.4%	$47.0M+0.2%

Not reported in any period shown, so not listed: Share Buybacks.

ALB Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALB quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	13.0%+11.8pp	1.2%-11.2pp	12.3%-29.7pp	42.0%+12.0pp	30.0%-1.8pp	31.8%-3.2pp	35.0%-1.0pp	36.1%+0.1pp	36.0%-0.2pp	36.2%+5.8pp	30.4%-1.1pp	31.5%-4.0pp	35.5%-0.2pp	35.7%-0.2pp	35.9%
Operating Margin	-7.1%+25.9pp	-33.0%-35.7pp	2.6%-31.1pp	33.7%+9.7pp	24.0%+7.8pp	16.2%-2.4pp	18.6%-8.5pp	27.0%+8.4pp	18.6%-3.8pp	22.4%+10.2pp	12.2%+1.1pp	11.1%-13.0pp	24.1%+8.2pp	15.9%-3.7pp	19.6%
Net Margin	-9.9%+12.0pp	-21.9%-38.3pp	16.4%-20.4pp	36.8%+33.0pp	3.7%-8.3pp	12.0%-2.9pp	14.9%-5.7pp	20.5%+18.8pp	1.8%-22.3pp	24.0%+12.2pp	11.8%+6.4pp	5.5%-11.8pp	17.3%+4.9pp	12.4%-2.4pp	14.8%
Return on Equity	-5.4%+6.5pp	-11.8%-28.6pp	16.7%-17.0pp	33.7%+31.5pp	2.2%-6.6pp	8.8%-4.8pp	13.6%-5.8pp	19.3%+17.8pp	1.5%-15.5pp	17.0%+6.7pp	10.3%+0.5pp	9.8%-15.6pp	25.4%+8.4pp	17.0%-7.7pp	24.6%
Return on Assets	-3.1%+4.0pp	-7.1%-15.7pp	8.6%-8.8pp	17.4%+16.3pp	1.1%-2.5pp	3.6%-1.8pp	5.4%-3.7pp	9.2%+8.4pp	0.7%-7.2pp	7.9%+4.4pp	3.5%+0.9pp	2.6%-9.0pp	11.5%+2.5pp	9.1%-3.2pp	12.2%
Current Ratio	2.23+0.3x	1.95+0.5x	1.47-0.4x	1.89+0.8x	1.06-0.2x	1.22-0.4x	1.58-0.1x	1.69-0.4x	2.06-0.8x	2.90+1.8x	1.13-1.8x	2.94-0.5x	3.40-0.3x	3.66+0.3x	3.38
Debt-to-Equity	0.330.0x	0.31-0.1x	0.380.0x	0.400.0x	0.36-0.3x	0.65-0.1x	0.73+0.3x	0.390.0x	0.39-0.2x	0.56-0.4x	0.97-0.7x	1.64+1.0x	0.65+0.3x	0.37-0.1x	0.47
Liabilities-to-Equity	0.72+0.1x	0.67-0.3x	0.940.0x	0.940.0x	0.95-0.5x	1.45-0.1x	1.51+0.4x	1.110.0x	1.110.0x	1.15-0.8x	1.95-0.9x	2.83+1.6x	1.20+0.3x	0.87-0.1x	1.01
Asset Turnover	0.310.0x	0.32-0.2x	0.53+0.1x	0.47+0.2x	0.300.0x	0.30-0.1x	0.36-0.1x	0.450.0x	0.40+0.1x	0.330.0x	0.29-0.2x	0.47-0.2x	0.67-0.1x	0.73-0.1x	0.83
FCF Margin	13.5%+31.9pp	-18.5%-9.8pp	-8.6%-17.5pp	8.9%+27.2pp	-18.3%-16.7pp	-1.7%+2.0pp	-3.7%+0.9pp	-4.6%-4.1pp	-0.4%-20.6pp	20.1%+15.4pp	4.7%-10.9pp	15.6%+4.0pp	11.6%+3.3pp	8.3%-2.9pp	11.2%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	33.9%+19.1pp	35.1%+20.6pp	13.9%+2.6pp	9.0%+16.7pp	14.8%+15.5pp	14.5%+11.7pp	11.2%+41.1pp	-7.7%-10.1pp
Operating Margin	26.0%+22.4pp	16.3%+14.5pp	-15.2%-15.6pp	-16.6%+65.3pp	3.6%+38.0pp	1.8%+15.0pp	0.4%+36.4pp	-81.8%-75.8pp
Net Margin	27.5%+25.8pp	22.3%+18.5pp	-29.0%-35.1pp	-12.3%+66.6pp	1.7%+14.9pp	3.8%+3.7pp	6.1%+32.3pp	-78.9%-92.0pp
Return on Equity	4.7%+4.5pp	3.2%+2.8pp	-4.3%-5.1pp	-1.6%+8.8pp	0.2%+1.9pp	0.4%+0.4pp	0.8%+7.3pp	-10.4%-13.5pp
Return on Assets	3.0%+2.9pp	2.1%+1.9pp	-2.5%-3.0pp	-0.9%+5.2pp	0.1%+1.1pp	0.2%+0.2pp	0.4%+3.8pp	-6.1%-7.7pp
Current Ratio	2.09-0.2x	2.070.0x	2.23+0.3x	2.27-0.2x	2.31-0.4x	2.11-0.7x	1.95+0.5x	2.44+0.6x
Debt-to-Equity	0.18-0.1x	0.18-0.1x	0.330.0x	0.320.0x	0.310.0x	0.310.0x	0.31-0.1x	0.350.0x
Liabilities-to-Equity	0.55-0.1x	0.54-0.2x	0.72+0.1x	0.720.0x	0.69+0.1x	0.700.0x	0.67-0.3x	0.70-0.2x
Asset Turnover	0.110.0x	0.090.0x	0.090.0x	0.080.0x	0.080.0x	0.060.0x	0.07-0.1x	0.080.0x
FCF Margin	36.6%+46.3pp	17.3%-16.5pp	16.3%+44.5pp	17.1%+22.7pp	-9.7%-3.8pp	33.9%+69.5pp	-28.2%+5.2pp	-5.6%-9.2pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Albemarle Corporation ALB	FY2025	$5.1B	-$510.6M	-9.9%	$11.0B	23/100
Eastman Chemical Company EMN	FY2025	$8.8B	$474.0M	5.4%	$7.4B	47/100
NewMarket Corporation NEU	FY2025	$2.7B	$418.7M	15.4%	$8.0B	66/100
Axalta Coating Systems Ltd. AXTA	FY2025	$5.1B	$378.0M	7.4%	$7.3B	54/100
Element Solutions Inc. ESI	FY2025	$2.6B	$190.8M	7.5%	$8.1B	60/100
Sasol Limited SSL	FY2025	$14.1B	$381.9M	2.7%	$11.6B	36/100

Where Albemarle Corporation Ranks

Frequently Asked Questions

What is Albemarle Corporation's annual revenue?

Albemarle Corporation (ALB) reported $5.1B in total revenue for fiscal year 2025. This represents a -4.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Albemarle Corporation's revenue growing?

Albemarle Corporation (ALB) revenue declined by 4.4% year-over-year, from $5.4B to $5.1B in fiscal year 2025.

Is Albemarle Corporation profitable?

Yes, Albemarle Corporation (ALB) reported a net income of $224.2M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $510.6M, with a net profit margin of -9.9%.

What is Albemarle Corporation's EBITDA?

Albemarle Corporation (ALB) had EBITDA of $291.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Albemarle Corporation have?

As of fiscal year 2025, Albemarle Corporation (ALB) had $1.6B in cash and equivalents against $3.1B in long-term debt.

What is Albemarle Corporation's gross margin?

Albemarle Corporation (ALB) had a gross margin of 13.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Albemarle Corporation's operating margin?

Albemarle Corporation (ALB) had an operating margin of -7.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Albemarle Corporation's net profit margin?

Albemarle Corporation (ALB) had a net profit margin of -9.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Albemarle Corporation pay dividends?

Yes, Albemarle Corporation (ALB) paid $1.62 per share in dividends during fiscal year 2025.

What is Albemarle Corporation's return on equity (ROE)?

Albemarle Corporation (ALB) has a return on equity of -5.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Albemarle Corporation's free cash flow?

Albemarle Corporation (ALB) generated $692.5M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Albemarle Corporation's operating cash flow?

Albemarle Corporation (ALB) generated $1.3B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Albemarle Corporation's total assets?

Albemarle Corporation (ALB) had $16.4B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Albemarle Corporation's capital expenditures?

Albemarle Corporation (ALB) invested $589.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Albemarle Corporation spend on research and development?

Albemarle Corporation (ALB) invested $51.4M in research and development during fiscal year 2025.

How many shares does Albemarle Corporation have outstanding?

Albemarle Corporation (ALB) had 118M shares outstanding as of fiscal year 2025.

What is Albemarle Corporation's current ratio?

Albemarle Corporation (ALB) had a current ratio of 2.23 as of fiscal year 2025, which is generally considered healthy.

What is Albemarle Corporation's debt-to-equity ratio?

Albemarle Corporation (ALB) had a debt-to-equity ratio of 0.33 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is Albemarle Corporation's liabilities-to-equity ratio?

Albemarle Corporation (ALB) had a liabilities-to-equity ratio of 0.72 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is Albemarle Corporation's return on assets (ROA)?

Albemarle Corporation (ALB) had a return on assets of -3.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Albemarle Corporation's P/E ratio?

Albemarle Corporation (ALB) trades at 49.2x earnings, its market capitalization divided by $224.2M net income, trailing 12 months to June 30, 2026. The market capitalization is $11.0B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Albemarle Corporation's price-to-sales ratio?

Albemarle Corporation (ALB) trades at 1.9x sales, its market capitalization divided by $5.9B revenue, trailing 12 months to June 30, 2026. The market capitalization is $11.0B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Albemarle Corporation's Altman Z-Score?

Albemarle Corporation (ALB) has an Altman Z-Score of 1.76, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Albemarle Corporation's Piotroski F-Score?

Albemarle Corporation (ALB) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Albemarle Corporation's earnings high quality?

Albemarle Corporation (ALB) reported a net loss of $510.6M while generating $1.3B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Albemarle Corporation cover its interest payments?

Albemarle Corporation (ALB) reported an operating loss of $367.1M against $207.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Albemarle Corporation?

Albemarle Corporation (ALB) scores 23 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.